Tuesday, March 17, 2026

Trump Backs Off, Calls on China to Make the First Move

Trump urges China to negotiate amid escalating trade tensions, highlighting a shift in strategy as both nations prepare for conflict.

ROMEO AND JULIET FROM HELL: The Twisted Internet Obsession With A Trump-Kim Wedding To End The Nuclear Crisis!

A viral meme suggests Barron Trump marry Kim Ju-ae for world peace, sparking mixed reactions on social media amid global tensions.

Japan’s Impressive Run at VNL 2024

The Japanese men's volleyball team clinched the...

Tag: biotechnology

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

Curiosis: Revolutionizing Bio Research with Automated Cell Imaging Systems

Curiosis enhances biomedical research with automated cell analysis, aiming for profitability and becoming a leading lab automation provider.

HLB BioStep Signs Strategic MOU with CLIPS BnC… Toward Integrated Preclinical and Clinical Development

HLB BioStep and CLIPS BnC sign MOU to enhance collaboration between preclinical and clinical stages of drug development.

GCCell Secures Groundbreaking Patent for Next-Gen Cell Therapy: What It Means for the Future of Immunotherapy

GC Cell has completed the registration of core technology patents for next-gen cell and gene therapies in South Korea and Japan.

Can AI Speed Up Drug R&D?: PharmGen Science Teams With Polaris AI Pharma Across the Full Development Cycle

PharmGen Science partners with Polaris AI Pharma to enhance drug development using AI technologies and optimize R&D processes.

Column-Free Antibody Purification Breakthrough: 97%+ Purity, 4x Faster, and 12x Fewer Impurities

KICET introduces a cost-effective antibody purification system using Tangential Flow Filtration, enhancing efficiency and purity in drug production.

Unlocking the Future of Healthcare: How Adaptive Clinical Trials Can Transform Regenerative Medicine in Asia

The article discusses South Korea's efforts to ease regulations on regenerative medicine to improve patient access while addressing significant challenges.

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

Daejeon University launched the 2025 Winter BioRG Training Program for biopharmaceuticals, featuring industry experts and hands-on sessions.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Xenovax PCM4: The Next-Gen Vaccine Transforming Pig Farming in Asia – Find Out How!

CARESIDE's swine vaccine technology certified as New Excellent Technology, enhancing protection and reducing farmer labor demands.

Unlocking the Future of Health Supplements: HLB Global and Nodcure’s Game-Changing Partnership

HLB Global partners with Nodcure for joint development of next-gen health supplements, aiming to innovate and expand market reach.

Revolutionizing Pharma: How LG CNS’s Agentic AI is Set to Transform Drug Development in South Korea

LG CNS expands its AI Transformation business into pharma, enhancing drug development with AI-driven platforms and automation services.

ABL206: First-in-Class Dual Antibody Drug Conjugate Approved for Clinical Trials in the U.S. – What This Means for Cancer Treatment

ABL Bio and Neok Bio received FDA approval for ABL206, a dual-antibody ADC, marking a key milestone in their clinical development efforts.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.